Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects
Clinical trial NCT00983099 · COMPLETED
Trial details
- NCT number
- NCT00983099
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-09-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.